S. M. Saiduzzaman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
S. M. Saiduzzaman has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Julker Neyen Sampad
School of Engineering
3 shared publications Aaron R. Hawkins
Electrical and Computer Engineering Department, Brigham Young University, Provo, USA
2 shared publicationsEphraim M. Ong
Electrical and Computer Engineering Department, Brigham Young University, Provo, USA
2 shared publicationsHolger Schmidt
School of Engineering, University of California, Santa Cruz, USA
2 shared publications- Holger Schmidt
University of California Santa Cruz
2 shared publications - Tanner Wells
Department of Electrical and Computer Engineering, Brigham Young University, Provo, UT 84602, USA
2 shared publications
Latest Publications
- Open Access
- 12 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Single molecule nanopore counting assay targeting small extracellular vesicle cargo for non-invasive monitoring of cerebral organoid development and health
Organoids are three-dimensional tissue cultures intended to replicate in vivo organs such that their function can be analyzed for applications in drug discovery, diagnostics, and research. This requires the ability to assess organoid health, development, and function on the cellular and molecular level, possibly frequently and over long periods of time. Here, we report an assay for monitoring organoid development and health by tracking the molecular cargo of small extracellular vesicles (sEV) with an integrated nanopore sensor chip. Specifically, we implement amplification-free and label-free quantification of the organoid stress marker ENO1 produced by cerebral organoid tissue. We demonstrate that mRNA levels measured non-invasively in sEVs are representative of the amounts measured by PCR measurements of the tissue cells. We also quantify the ENO1 RNA load in sEVs over the course of 15 weeks and show that ENO1 expression levels are correlated with other physiological parameters such as organoid glucose consumption. These results illustrate the capability of single molecule nanopore sensors for providing simple, continuous, quantitative assessment of organoids’ phenotypes on the molecular level. This approach can be expanded to other molecular biomarkers such as protein transcripts, multiplexed analysis, and fully integrated in-line analysis in an automated tissue culture platform.
- 12 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Open AccessSingle molecule nanopore counting assay targeting small extracellular vesicle cargo for non-invasive monitoring of cerebral organoid development and health
Organoids are three-dimensional tissue cultures intended to replicate in vivo organs such that their function can be analyzed for applications in drug discovery, diagnostics, and research. This requires the ability to assess organoid health, development, and function on the cellular and molecular level, possibly frequently and over long periods of time. Here, we report an assay for monitoring organoid development and health by tracking the molecular cargo of small extracellular vesicles (sEV) with an integrated nanopore sensor chip. Specifically, we implement amplification-free and label-free quantification of the organoid stress marker ENO1 produced by cerebral organoid tissue. We demonstrate that mRNA levels measured non-invasively in sEVs are representative of the amounts measured by PCR measurements of the tissue cells. We also quantify the ENO1 RNA load in sEVs over the course of 15 weeks and show that ENO1 expression levels are correlated with other physiological parameters such as organoid glucose consumption. These results illustrate the capability of single molecule nanopore sensors for providing simple, continuous, quantitative assessment of organoids’ phenotypes on the molecular level. This approach can be expanded to other molecular biomarkers such as protein transcripts, multiplexed analysis, and fully integrated in-line analysis in an automated tissue culture platform.
- 12 August 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (8) , 5772-5780
Universal Nanopore Sensor for Amplification-Free and Label-Free Detection of Molecular Biomarkers
Molecular diagnostics of biomarkers derived from tissues and bodily fluids are developing into a cornerstone of medical testing and potentially the foundation of a personalized medicine approach. Therefore, there is a need for universal biosensors capable of detecting different biomarker types with high performance and minimal complexity, ideally suitable for point-of-care use. Here, we present an integrated nanopore sensor for amplification-free, label-free, and quantitative detection of both proteins and nucleic acids from clinical samples. High performance is enabled by trapping target-carrying microbeads at the nanopore location and rapid detection of individual targets upon release from the beads. Low complexity is achieved via a simple solid-phase extraction protocol and optics-free, flow-based bead trapping. The device is validated through the analysis of biofluids from a baboon infected with SARS-CoV-2. Detection of the spike protein down to 100 fg/mL, with a linear count over 5 orders of magnitude, and SARS-CoV-2 RNA over the entire course of infection, down to a concentration of 7.5 aM, are demonstrated. This platform enables ultrasensitive, quantitative analysis of different biomarker types using a single protocol and holds promise as a universal biosensor for infectious disease detection and a wide range of applications.
- 12 August 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (8) , 5772-5780
Universal Nanopore Sensor for Amplification-Free and Label-Free Detection of Molecular Biomarkers
Molecular diagnostics of biomarkers derived from tissues and bodily fluids are developing into a cornerstone of medical testing and potentially the foundation of a personalized medicine approach. Therefore, there is a need for universal biosensors capable of detecting different biomarker types with high performance and minimal complexity, ideally suitable for point-of-care use. Here, we present an integrated nanopore sensor for amplification-free, label-free, and quantitative detection of both proteins and nucleic acids from clinical samples. High performance is enabled by trapping target-carrying microbeads at the nanopore location and rapid detection of individual targets upon release from the beads. Low complexity is achieved via a simple solid-phase extraction protocol and optics-free, flow-based bead trapping. The device is validated through the analysis of biofluids from a baboon infected with SARS-CoV-2. Detection of the spike protein down to 100 fg/mL, with a linear count over 5 orders of magnitude, and SARS-CoV-2 RNA over the entire course of infection, down to a concentration of 7.5 aM, are demonstrated. This platform enables ultrasensitive, quantitative analysis of different biomarker types using a single protocol and holds promise as a universal biosensor for infectious disease detection and a wide range of applications.
- Open Access
- 10 April 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (16)
Label-free and amplification-free viral RNA quantification from primate biofluids using a trapping-assisted optofluidic nanopore platform
Viral outbreaks can cause widespread disruption, creating the need for diagnostic tools that provide high performance and sample versatility at the point of use with moderate complexity. Current gold standards such as PCR and rapid antigen tests fall short in one or more of these aspects. Here, we report a label-free and amplification-free nanopore sensor platform that overcomes these challenges via direct detection and quantification of viral RNA in clinical samples from a variety of biological fluids. The assay uses an optofluidic chip that combines optical waveguides with a fluidic channel and integrates a solid-state nanopore for sensing of individual biomolecules upon translocation through the pore. High specificity and low limit of detection are ensured by capturing RNA targets on microbeads and collecting them by optical trapping at the nanopore location where targets are released and rapidly detected. We use this device for longitudinal studies of the viral load progression for Zika and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in marmoset and baboon animal models, respectively. The up to million-fold trapping-based target concentration enhancement enables amplification-free RNA quantification across the clinically relevant concentration range down to the assay limit of RT-qPCR as well as cases in which PCR failed. The assay operates across all relevant biofluids, including semen, urine, and whole blood for Zika and nasopharyngeal and throat swab, rectal swab, and bronchoalveolar lavage for SARS-CoV-2. The versatility, performance, simplicity, and potential for full microfluidic integration of the amplification-free nanopore assay points toward a unique approach to molecular diagnostics for nucleic acids, proteins, and other targets.
- 10 April 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (16)
Open AccessLabel-free and amplification-free viral RNA quantification from primate biofluids using a trapping-assisted optofluidic nanopore platform
Viral outbreaks can cause widespread disruption, creating the need for diagnostic tools that provide high performance and sample versatility at the point of use with moderate complexity. Current gold standards such as PCR and rapid antigen tests fall short in one or more of these aspects. Here, we report a label-free and amplification-free nanopore sensor platform that overcomes these challenges via direct detection and quantification of viral RNA in clinical samples from a variety of biological fluids. The assay uses an optofluidic chip that combines optical waveguides with a fluidic channel and integrates a solid-state nanopore for sensing of individual biomolecules upon translocation through the pore. High specificity and low limit of detection are ensured by capturing RNA targets on microbeads and collecting them by optical trapping at the nanopore location where targets are released and rapidly detected. We use this device for longitudinal studies of the viral load progression for Zika and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in marmoset and baboon animal models, respectively. The up to million-fold trapping-based target concentration enhancement enables amplification-free RNA quantification across the clinically relevant concentration range down to the assay limit of RT-qPCR as well as cases in which PCR failed. The assay operates across all relevant biofluids, including semen, urine, and whole blood for Zika and nasopharyngeal and throat swab, rectal swab, and bronchoalveolar lavage for SARS-CoV-2. The versatility, performance, simplicity, and potential for full microfluidic integration of the amplification-free nanopore assay points toward a unique approach to molecular diagnostics for nucleic acids, proteins, and other targets.
- Open Access
- 27 August 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (9) , 690
Optofluidic Particle Manipulation: Optical Trapping in a Thin-Membrane Microchannel
We demonstrate an optofluidic device which utilizes the optical scattering and gradient forces for particle trapping in microchannels featuring 300 nm thick membranes. On-chip waveguides are used to direct light into microfluidic trapping channels. Radiation pressure is used to push particles into a protrusion cavity, isolating the particles from liquid flow. Two different designs are presented: the first exclusively uses the optical scattering force for particle manipulation, and the second uses both scattering and gradient forces. Trapping performance is modeled for both cases. The first design, referred to as the orthogonal force design, is shown to have a 80% capture efficiency under typical operating conditions. The second design, referred to as the gradient force design, is shown to have 98% efficiency under the same conditions.
- 27 August 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (9) , 690
Open AccessOptofluidic Particle Manipulation: Optical Trapping in a Thin-Membrane Microchannel
We demonstrate an optofluidic device which utilizes the optical scattering and gradient forces for particle trapping in microchannels featuring 300 nm thick membranes. On-chip waveguides are used to direct light into microfluidic trapping channels. Radiation pressure is used to push particles into a protrusion cavity, isolating the particles from liquid flow. Two different designs are presented: the first exclusively uses the optical scattering force for particle manipulation, and the second uses both scattering and gradient forces. Trapping performance is modeled for both cases. The first design, referred to as the orthogonal force design, is shown to have a 80% capture efficiency under typical operating conditions. The second design, referred to as the gradient force design, is shown to have 98% efficiency under the same conditions.